Cell Line Generation Market, Global Outlook and Forecast 2022-2028

April 2022 | 103 pages | ID: CDF2FC3EB739EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cell Line Generation in Global, including the following market information:

Global Cell Line Generation Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cell Line Generation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Overexpression Stable Cell Lines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell Line Generation include Merck KGaA, VectorBuilder, Thermo Fisher Scientific, Creative Biogene, Molecular Devices, LLC, Esco Aster Pte, ALSTEM, Inc., Creative BioMart and Altogen Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Line Generation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell Line Generation Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cell Line Generation Market Segment Percentages, by Type, 2021 (%)

• Overexpression Stable Cell Lines
• Shrna Knockdown Stable Cell Lines
• Tet Inducible Gene Expression Stable Cell Lines
• Crispr Stable Cell Lines

Global Cell Line Generation Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cell Line Generation Market Segment Percentages, by Application, 2021 (%)

• Medical Industry
• Biological Industry
• Others

Global Cell Line Generation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cell Line Generation Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell Line Generation revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cell Line Generation revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck KGaA
• VectorBuilder
• Thermo Fisher Scientific
• Creative Biogene
• Molecular Devices, LLC
• Esco Aster Pte
• ALSTEM, Inc.
• Creative BioMart
• Altogen Labs
• SB Drug Discovery
• BPS Bioscience, Inc.
• ProteoGenix
• Biologics International Corp (BIC)
• Advanced Instruments
• Sphere Fluidics Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell Line Generation Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell Line Generation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL LINE GENERATION OVERALL MARKET SIZE

2.1 Global Cell Line Generation Market Size: 2021 VS 2028
2.2 Global Cell Line Generation Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell Line Generation Players in Global Market
3.2 Top Global Cell Line Generation Companies Ranked by Revenue
3.3 Global Cell Line Generation Revenue by Companies
3.4 Top 3 and Top 5 Cell Line Generation Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell Line Generation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Line Generation Players in Global Market
  3.6.1 List of Global Tier 1 Cell Line Generation Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell Line Generation Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cell Line Generation Market Size Markets, 2021 & 2028
  4.1.2 Overexpression Stable Cell Lines
  4.1.3 Shrna Knockdown Stable Cell Lines
  4.1.4 Tet Inducible Gene Expression Stable Cell Lines
  4.1.5 Crispr Stable Cell Lines
4.2 By Type - Global Cell Line Generation Revenue & Forecasts
  4.2.1 By Type - Global Cell Line Generation Revenue, 2017-2022
  4.2.2 By Type - Global Cell Line Generation Revenue, 2023-2028
  4.2.3 By Type - Global Cell Line Generation Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell Line Generation Market Size, 2021 & 2028
  5.1.2 Medical Industry
  5.1.3 Biological Industry
  5.1.4 Others
5.2 By Application - Global Cell Line Generation Revenue & Forecasts
  5.2.1 By Application - Global Cell Line Generation Revenue, 2017-2022
  5.2.2 By Application - Global Cell Line Generation Revenue, 2023-2028
  5.2.3 By Application - Global Cell Line Generation Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cell Line Generation Market Size, 2021 & 2028
6.2 By Region - Global Cell Line Generation Revenue & Forecasts
  6.2.1 By Region - Global Cell Line Generation Revenue, 2017-2022
  6.2.2 By Region - Global Cell Line Generation Revenue, 2023-2028
  6.2.3 By Region - Global Cell Line Generation Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cell Line Generation Revenue, 2017-2028
  6.3.2 US Cell Line Generation Market Size, 2017-2028
  6.3.3 Canada Cell Line Generation Market Size, 2017-2028
  6.3.4 Mexico Cell Line Generation Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cell Line Generation Revenue, 2017-2028
  6.4.2 Germany Cell Line Generation Market Size, 2017-2028
  6.4.3 France Cell Line Generation Market Size, 2017-2028
  6.4.4 U.K. Cell Line Generation Market Size, 2017-2028
  6.4.5 Italy Cell Line Generation Market Size, 2017-2028
  6.4.6 Russia Cell Line Generation Market Size, 2017-2028
  6.4.7 Nordic Countries Cell Line Generation Market Size, 2017-2028
  6.4.8 Benelux Cell Line Generation Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cell Line Generation Revenue, 2017-2028
  6.5.2 China Cell Line Generation Market Size, 2017-2028
  6.5.3 Japan Cell Line Generation Market Size, 2017-2028
  6.5.4 South Korea Cell Line Generation Market Size, 2017-2028
  6.5.5 Southeast Asia Cell Line Generation Market Size, 2017-2028
  6.5.6 India Cell Line Generation Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cell Line Generation Revenue, 2017-2028
  6.6.2 Brazil Cell Line Generation Market Size, 2017-2028
  6.6.3 Argentina Cell Line Generation Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell Line Generation Revenue, 2017-2028
  6.7.2 Turkey Cell Line Generation Market Size, 2017-2028
  6.7.3 Israel Cell Line Generation Market Size, 2017-2028
  6.7.4 Saudi Arabia Cell Line Generation Market Size, 2017-2028
  6.7.5 UAE Cell Line Generation Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck KGaA
  7.1.1 Merck KGaA Corporate Summary
  7.1.2 Merck KGaA Business Overview
  7.1.3 Merck KGaA Cell Line Generation Major Product Offerings
  7.1.4 Merck KGaA Cell Line Generation Revenue in Global Market (2017-2022)
  7.1.5 Merck KGaA Key News
7.2 VectorBuilder
  7.2.1 VectorBuilder Corporate Summary
  7.2.2 VectorBuilder Business Overview
  7.2.3 VectorBuilder Cell Line Generation Major Product Offerings
  7.2.4 VectorBuilder Cell Line Generation Revenue in Global Market (2017-2022)
  7.2.5 VectorBuilder Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Cell Line Generation Major Product Offerings
  7.3.4 Thermo Fisher Scientific Cell Line Generation Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Creative Biogene
  7.4.1 Creative Biogene Corporate Summary
  7.4.2 Creative Biogene Business Overview
  7.4.3 Creative Biogene Cell Line Generation Major Product Offerings
  7.4.4 Creative Biogene Cell Line Generation Revenue in Global Market (2017-2022)
  7.4.5 Creative Biogene Key News
7.5 Molecular Devices, LLC
  7.5.1 Molecular Devices, LLC Corporate Summary
  7.5.2 Molecular Devices, LLC Business Overview
  7.5.3 Molecular Devices, LLC Cell Line Generation Major Product Offerings
  7.5.4 Molecular Devices, LLC Cell Line Generation Revenue in Global Market (2017-2022)
  7.5.5 Molecular Devices, LLC Key News
7.6 Esco Aster Pte
  7.6.1 Esco Aster Pte Corporate Summary
  7.6.2 Esco Aster Pte Business Overview
  7.6.3 Esco Aster Pte Cell Line Generation Major Product Offerings
  7.6.4 Esco Aster Pte Cell Line Generation Revenue in Global Market (2017-2022)
  7.6.5 Esco Aster Pte Key News
7.7 ALSTEM, Inc.
  7.7.1 ALSTEM, Inc. Corporate Summary
  7.7.2 ALSTEM, Inc. Business Overview
  7.7.3 ALSTEM, Inc. Cell Line Generation Major Product Offerings
  7.7.4 ALSTEM, Inc. Cell Line Generation Revenue in Global Market (2017-2022)
  7.7.5 ALSTEM, Inc. Key News
7.8 Creative BioMart
  7.8.1 Creative BioMart Corporate Summary
  7.8.2 Creative BioMart Business Overview
  7.8.3 Creative BioMart Cell Line Generation Major Product Offerings
  7.8.4 Creative BioMart Cell Line Generation Revenue in Global Market (2017-2022)
  7.8.5 Creative BioMart Key News
7.9 Altogen Labs
  7.9.1 Altogen Labs Corporate Summary
  7.9.2 Altogen Labs Business Overview
  7.9.3 Altogen Labs Cell Line Generation Major Product Offerings
  7.9.4 Altogen Labs Cell Line Generation Revenue in Global Market (2017-2022)
  7.9.5 Altogen Labs Key News
7.10 SB Drug Discovery
  7.10.1 SB Drug Discovery Corporate Summary
  7.10.2 SB Drug Discovery Business Overview
  7.10.3 SB Drug Discovery Cell Line Generation Major Product Offerings
  7.10.4 SB Drug Discovery Cell Line Generation Revenue in Global Market (2017-2022)
  7.10.5 SB Drug Discovery Key News
7.11 BPS Bioscience, Inc.
  7.11.1 BPS Bioscience, Inc. Corporate Summary
  7.11.2 BPS Bioscience, Inc. Business Overview
  7.11.3 BPS Bioscience, Inc. Cell Line Generation Major Product Offerings
  7.11.4 BPS Bioscience, Inc. Cell Line Generation Revenue in Global Market (2017-2022)
  7.11.5 BPS Bioscience, Inc. Key News
7.12 ProteoGenix
  7.12.1 ProteoGenix Corporate Summary
  7.12.2 ProteoGenix Business Overview
  7.12.3 ProteoGenix Cell Line Generation Major Product Offerings
  7.12.4 ProteoGenix Cell Line Generation Revenue in Global Market (2017-2022)
  7.12.5 ProteoGenix Key News
7.13 Biologics International Corp (BIC)
  7.13.1 Biologics International Corp (BIC) Corporate Summary
  7.13.2 Biologics International Corp (BIC) Business Overview
  7.13.3 Biologics International Corp (BIC) Cell Line Generation Major Product Offerings
  7.13.4 Biologics International Corp (BIC) Cell Line Generation Revenue in Global Market (2017-2022)
  7.13.5 Biologics International Corp (BIC) Key News
7.14 Advanced Instruments
  7.14.1 Advanced Instruments Corporate Summary
  7.14.2 Advanced Instruments Business Overview
  7.14.3 Advanced Instruments Cell Line Generation Major Product Offerings
  7.14.4 Advanced Instruments Cell Line Generation Revenue in Global Market (2017-2022)
  7.14.5 Advanced Instruments Key News
7.15 Sphere Fluidics Limited
  7.15.1 Sphere Fluidics Limited Corporate Summary
  7.15.2 Sphere Fluidics Limited Business Overview
  7.15.3 Sphere Fluidics Limited Cell Line Generation Major Product Offerings
  7.15.4 Sphere Fluidics Limited Cell Line Generation Revenue in Global Market (2017-2022)
  7.15.5 Sphere Fluidics Limited Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cell Line Generation Market Opportunities & Trends in Global Market
Table 2. Cell Line Generation Market Drivers in Global Market
Table 3. Cell Line Generation Market Restraints in Global Market
Table 4. Key Players of Cell Line Generation in Global Market
Table 5. Top Cell Line Generation Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell Line Generation Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell Line Generation Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell Line Generation Product Type
Table 9. List of Global Tier 1 Cell Line Generation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Line Generation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell Line Generation Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell Line Generation Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell Line Generation Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell Line Generation Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell Line Generation Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell Line Generation Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell Line Generation Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell Line Generation Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell Line Generation Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell Line Generation Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell Line Generation Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell Line Generation Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell Line Generation Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell Line Generation Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell Line Generation Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell Line Generation Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell Line Generation Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell Line Generation Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell Line Generation Revenue, (US$, Mn), 2023-2028
Table 30. Merck KGaA Corporate Summary
Table 31. Merck KGaA Cell Line Generation Product Offerings
Table 32. Merck KGaA Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 33. VectorBuilder Corporate Summary
Table 34. VectorBuilder Cell Line Generation Product Offerings
Table 35. VectorBuilder Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Cell Line Generation Product Offerings
Table 38. Thermo Fisher Scientific Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 39. Creative Biogene Corporate Summary
Table 40. Creative Biogene Cell Line Generation Product Offerings
Table 41. Creative Biogene Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 42. Molecular Devices, LLC Corporate Summary
Table 43. Molecular Devices, LLC Cell Line Generation Product Offerings
Table 44. Molecular Devices, LLC Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 45. Esco Aster Pte Corporate Summary
Table 46. Esco Aster Pte Cell Line Generation Product Offerings
Table 47. Esco Aster Pte Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 48. ALSTEM, Inc. Corporate Summary
Table 49. ALSTEM, Inc. Cell Line Generation Product Offerings
Table 50. ALSTEM, Inc. Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 51. Creative BioMart Corporate Summary
Table 52. Creative BioMart Cell Line Generation Product Offerings
Table 53. Creative BioMart Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 54. Altogen Labs Corporate Summary
Table 55. Altogen Labs Cell Line Generation Product Offerings
Table 56. Altogen Labs Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 57. SB Drug Discovery Corporate Summary
Table 58. SB Drug Discovery Cell Line Generation Product Offerings
Table 59. SB Drug Discovery Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 60. BPS Bioscience, Inc. Corporate Summary
Table 61. BPS Bioscience, Inc. Cell Line Generation Product Offerings
Table 62. BPS Bioscience, Inc. Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 63. ProteoGenix Corporate Summary
Table 64. ProteoGenix Cell Line Generation Product Offerings
Table 65. ProteoGenix Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 66. Biologics International Corp (BIC) Corporate Summary
Table 67. Biologics International Corp (BIC) Cell Line Generation Product Offerings
Table 68. Biologics International Corp (BIC) Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 69. Advanced Instruments Corporate Summary
Table 70. Advanced Instruments Cell Line Generation Product Offerings
Table 71. Advanced Instruments Cell Line Generation Revenue (US$, Mn), (2017-2022)
Table 72. Sphere Fluidics Limited Corporate Summary
Table 73. Sphere Fluidics Limited Cell Line Generation Product Offerings
Table 74. Sphere Fluidics Limited Cell Line Generation Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cell Line Generation Segment by Type in 2021
Figure 2. Cell Line Generation Segment by Application in 2021
Figure 3. Global Cell Line Generation Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell Line Generation Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell Line Generation Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Line Generation Revenue in 2021
Figure 8. By Type - Global Cell Line Generation Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell Line Generation Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell Line Generation Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell Line Generation Revenue Market Share, 2017-2028
Figure 12. US Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell Line Generation Revenue Market Share, 2017-2028
Figure 16. Germany Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell Line Generation Revenue Market Share, 2017-2028
Figure 24. China Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell Line Generation Revenue Market Share, 2017-2028
Figure 30. Brazil Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell Line Generation Revenue Market Share, 2017-2028
Figure 33. Turkey Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell Line Generation Revenue, (US$, Mn), 2017-2028
Figure 37. Merck KGaA Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. VectorBuilder Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Creative Biogene Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Molecular Devices, LLC Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Esco Aster Pte Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ALSTEM, Inc. Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Creative BioMart Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Altogen Labs Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SB Drug Discovery Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. BPS Bioscience, Inc. Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ProteoGenix Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Biologics International Corp (BIC) Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Advanced Instruments Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sphere Fluidics Limited Cell Line Generation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)